The burgeoning popularity of tirzepatide , initially for diabetes , is creating significant buzz within the United Kingdom , prompting a notable shift in hormone trends. Availability these medications remains a complex landscape, with National Health Service provision currently limited and specialist practices offering prescriptions at a higher cos